EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cortical and Corticomuscular Beta‐Gamma Phase‐Amplitude Coupling During Different Locomotion States and the Effects of Levodopa in Parkinson's Disease

Haifeng Zhao iD, Shenglin Hao, Peiran Zhang, Shenghong He iD, Laura Wehmeyer, Ziyi Feng, Lu Xu, Shikun Zhan, Wei Liu, Xiaoxiao Zhang, Marie-Laure Welter iD, Dianyou Li und 4 weitere

Movement Disorders · 2025

DOI: 10.1002/mds.70031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, 2025. Verfasst von Haifeng Zhao und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Functional Neurosurgery, Affiliated Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Parkinson Disease, Levodopa, Antiparkinson Agents, Beta Rhythm. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Commission of Shanghai Municipality, China Postdoctoral Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Phase‐amplitude coupling (PAC) in the beta‐gamma range has emerged as a promising electrophysiological biomarker of Parkinson's disease (PD).

Objective

This study aims to investigate how levodopa and locomotion modulate cortical (central electroencephalogram [cEEG]) and corticomuscular (cEEG‐gEMG [gastrocnemius electromyography]) beta‐gamma PAC in patients with PD.

Methods

Thirty patients with PD underwent simultaneous cEEG and gEMG recordings during sitting, standing, and free walking in both off and on dopaminergic states. Spectral features and PAC analyses were conducted to assess the effects of levodopa, locomotion, and their associations with motor symptoms.

Results

In the off levodopa state, patients showed prolonged gait cycle intervals and shorter step lengths, correlating with higher Movement Disorder Society–revised Unified Parkinson's Disease Rating Scale Part III (UPDRS‐III) scores. The cEEG beta‐gamma PAC during sitting and standing, and cEEG‐gEMG beta‐gamma PAC during walking, positively correlated with UPDRS‐III in the off levodopa state. The cEEG alpha/low beta‐gamma and cEEG‐gEMG low beta‐gamma PAC increased from on to off levodopa while walking, with the latter correlating with reduced step length. Step event–related PAC analysis unveiled a dynamic enhancement of alpha/beta cEEG‐gamma gEMG PAC around heel strikes in on levodopa compared with off .

Conclusions

Both cortical and corticomuscular beta‐gamma PACs are modulated by levodopa and locomotion, with low beta‐gamma corticomuscular PAC specifically linked to gait dysfunction. Moreover, the levodopa‐related enhancement of alpha/beta–gamma PAC during heel strikes highlights the functional relevance of dopaminergic modulation during gait. These findings highlight the potential of PAC as a biomarker for PD, particularly in the development of gait phase‐locked adaptive deep brain stimulation strategies for patients with PD guided by noninvasive PAC monitoring. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseLevodopaAntiparkinson AgentsBeta RhythmGamma RhythmLocomotionMuscle, SkeletalCerebral CortexMotor CortexHumansMaleFemaleAgedMiddle AgedElectromyographyElectroencephalographyWalking

Stichwörter der Autor:innen

Parkinson's diseasecorticomuscular connectivitygait dysfunctionmotor cortexphase‐amplitude coupling

Substanzen

LevodopaAntiparkinson Agents

Autor:innen und Institutionen

  • Department of Functional Neurosurgery, Affiliated Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Radiology, Affiliated Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Clinical Neuroscience Center, Affiliated Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Clinical Neuroscience Center, Affiliated Ruijin Hospital Luwan Branch, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • MRC Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
  • Paris Brain Institute, CNRS UMR 7225, INSERM 1127, Sorbonne University, Paris, France.

ORCID-Profile: Haifeng Zhao, Shenghong He, Marie-Laure Welter, Huiling Tan, Chunyan Cao

Förderung

  • Science and Technology Commission of Shanghai Municipality
  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Zhao, H., Hao, S., Zhang, P., He, S., Wehmeyer, L., Feng, Z., Xu, L., Zhan, S., Liu, W., Zhang, X., Welter, M. L., Li, D., Sun, B., Lu, Y., Tan, H., & Cao, C. (2025). Cortical and Corticomuscular Beta‐Gamma Phase‐Amplitude Coupling During Different Locomotion States and the Effects of Levodopa in Parkinson's Disease. Movement Disorders. https://doi.org/10.1002/mds.70031

Vancouver

Zhao H, Hao S, Zhang P, He S, Wehmeyer L, Feng Z, et al. Cortical and Corticomuscular Beta‐Gamma Phase‐Amplitude Coupling During Different Locomotion States and the Effects of Levodopa in Parkinson's Disease. Movement Disorders. 2025. doi:10.1002/mds.70031

BibTeX
@article{Zhao2025,
  author = {Zhao, Haifeng and Hao, Shenglin and Zhang, Peiran and He, Shenghong and Wehmeyer, Laura and Feng, Ziyi and Xu, Lu and Zhan, Shikun and Liu, Wei and Zhang, Xiaoxiao and Welter, Marie-Laure and Li, Dianyou and Sun, Bomin and Lu, Yong and Tan, Huiling and Cao, Chunyan},
  title = {Cortical and Corticomuscular Beta‐Gamma Phase‐Amplitude Coupling During Different Locomotion States and the Effects of Levodopa in Parkinson's Disease},
  journal = {Movement Disorders},
  year = {2025},
  doi = {10.1002/mds.70031}
}
Kostenlos starten →